메뉴 건너뛰기




Volumn 34, Issue 1, 2003, Pages 22-25

Risk of fatal stroke in patients with treated familial hypercholesterolemia: A prospective registry study

Author keywords

Familial; Hypercholesterolemia; Mortality; Stroke

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

EID: 0037229190     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000047123.14312.3E     Document Type: Article
Times cited : (45)

References (27)
  • 2
    • 0016373413 scopus 로고
    • Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia
    • Stone NJ, Levy RI, Fredrickson DS, Vetter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation. 1974;49:476-488.
    • (1974) Circulation , vol.49 , pp. 476-488
    • Stone, N.J.1    Levy, R.I.2    Fredrickson, D.S.3    Vetter, J.4
  • 3
    • 0014693152 scopus 로고
    • Risks of ischaemic heart disease in familial hyperlipidaemic states
    • Slack J. Risks of ischaemic heart disease in familial hyperlipidaemic states. Lancet. 1969;2:1380-1382.
    • (1969) Lancet , vol.2 , pp. 1380-1382
    • Slack, J.1
  • 4
    • 0025944056 scopus 로고
    • The risk of fatal coronary heart disease in familial hypercholesterolemia
    • Scientific Steering Committee on behalf of The Simon Broome Register Group. The risk of fatal coronary heart disease in familial hypercholesterolemia. BMJ. 1991;303:893-896.
    • (1991) BMJ , vol.303 , pp. 893-896
  • 5
    • 0032890205 scopus 로고    scopus 로고
    • Mortality in treated heterozygous familial hypercholesterolemia: Implications for patient management
    • Scientific Steering Committee on behalf of Simon Broome Familial Hyperlipidaemia Register Group. Mortality in treated heterozygous familial hypercholesterolemia: implications for patient management. Atherosclerosis. 1999;142:105-112.
    • (1999) Atherosclerosis , vol.142 , pp. 105-112
  • 7
    • 0026031715 scopus 로고
    • Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia
    • Hill JS, Hayden MR, Frohlich J, Pritchard PH. Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb, 1991;11:290-297.
    • (1991) Arterioscler Thromb , vol.11 , pp. 290-297
    • Hill, J.S.1    Hayden, M.R.2    Frohlich, J.3    Pritchard, P.H.4
  • 8
    • 0028810389 scopus 로고
    • The prevalence of peripheral vascular disease in familial hypercholesterolemia
    • Kroon AA, Ajubi N, Van Asten WNJC, Stalenhoef AFH. The prevalence of peripheral vascular disease in familial hypercholesterolemia. J Intern Med. 1995;238:451-459.
    • (1995) J Intern Med , vol.238 , pp. 451-459
    • Kroon, A.A.1    Ajubi, N.2    Van Asten, W.N.J.C.3    Stalenhoef, A.F.H.4
  • 9
    • 0032845310 scopus 로고    scopus 로고
    • Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease
    • Wittekoek ME, de Groot E, Prins MH, Trip MD, Buller HR, Kastelein JJP. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis. 1999;146:271-279.
    • (1999) Atherosclerosis , vol.146 , pp. 271-279
    • Wittekoek, M.E.1    De Groot, E.2    Prins, M.H.3    Trip, M.D.4    Buller, H.R.5    Kastelein, J.J.P.6
  • 10
    • 0023244725 scopus 로고
    • Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid
    • Kuo PT Tole JF, Schaaf JA, Jones A, Wilson AC, Kostis JB. Moreyra AE. Extracranial carotid arterial disease in patients with familial hypercholesterolemia and coronary artery disease treated with colestipol and nicotinic acid. Stroke. 1987;18:716-721.
    • (1987) Stroke , vol.18 , pp. 716-721
    • Kuo, P.T.1    Tole, J.F.2    Schaaf, J.A.3    Jones, A.4    Wilson, A.C.5    Kostis, J.B.6    Moreyra, A.E.7
  • 12
    • 0023786592 scopus 로고
    • Risk of brain infarction in familial hypercholesterolemia
    • Kaste M, Koivisto P. Risk of brain infarction in familial hypercholesterolemia. Stroke. 1988;19:1097-1100.
    • (1988) Stroke , vol.19 , pp. 1097-1100
    • Kaste, M.1    Koivisto, P.2
  • 14
    • 0015348189 scopus 로고
    • Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge
    • Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
    • (1972) Clin Chem , vol.18 , pp. 499-502
    • Friedewald, W.T.1    Levy, R.I.2    Fredickson, D.S.3
  • 15
    • 0034662322 scopus 로고    scopus 로고
    • The extent of under-diagnosis of familial hypercholesterolemia in routine practice: Results of a prospective register study
    • Neil HA, Hammond T, Huxley R, Matthews DR, Humphries SE. The extent of under-diagnosis of familial hypercholesterolemia in routine practice: Results of a prospective register study. BMJ. 2000;321:148.
    • (2000) BMJ , vol.321 , pp. 148
    • Neil, H.A.1    Hammond, T.2    Huxley, R.3    Matthews, D.R.4    Humphries, S.E.5
  • 16
    • 0022572169 scopus 로고
    • Cohort study analysis with a Fortran computer program
    • Coleman M, Douglas A, Hermon C, Peto J. Cohort study analysis with a Fortran computer program. Int J Epidemiol, 1986;15:134-137.
    • (1986) Int J Epidemiol , vol.15 , pp. 134-137
    • Coleman, M.1    Douglas, A.2    Hermon, C.3    Peto, J.4
  • 19
    • 0035058910 scopus 로고    scopus 로고
    • A molecular genetic service for diagnosing individuals with familial hypercholesterolemia (FH) in the United Kingdom
    • Heath KE, Humphries SE, Middleton-Price H, Boxer M. A molecular genetic service for diagnosing individuals with familial hypercholesterolemia (FH) in the United Kingdom. Eur J Hum Genet. 2001;9:244-252.
    • (2001) Eur J Hum Genet , vol.9 , pp. 244-252
    • Heath, K.E.1    Humphries, S.E.2    Middleton-Price, H.3    Boxer, M.4
  • 21
    • 0030804432 scopus 로고    scopus 로고
    • Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease
    • Benesch C, Witter DM, Wilder AL, Duncan PW, Samsa GP. Matchar DB. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology. 1997;49:660-664.
    • (1997) Neurology , vol.49 , pp. 660-664
    • Benesch, C.1    Witter, D.M.2    Wilder, A.L.3    Duncan, P.W.4    Samsa, G.P.5    Matchar, D.B.6
  • 24
    • 0343273397 scopus 로고
    • Cholesterol, diastolic blood pressure, and stroke: 13,000 Strokes in 450,000 people in 45 prospective cohorts
    • Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Lancet. 1995;346:1647-1653.
    • (1995) Lancet , vol.346 , pp. 1647-1653
  • 25
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet. 2002;360:7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 27
    • 0035941786 scopus 로고    scopus 로고
    • Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): A prospective, randomised, double-blind trial
    • Smilde TJ, van Wissen S, Wollersheim H. Trip MD, Kastelein JJP. Stalenhoef AFH. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolemia (ASAP): A prospective, randomised, double-blind trial. Lancet. 2001;357:577-81.
    • (2001) Lancet , vol.357 , pp. 577-581
    • Smilde, T.J.1    Van Wissen, S.2    Wollersheim, H.3    Trip, M.D.4    Kastelein, J.J.P.5    Stalenhoef, A.F.H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.